BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36764998)

  • 41. Preclinical evaluation of perifosine as a potential promising anti-rhabdomyosarcoma agent.
    Shen J; Hong Y; Zhao Q; Zhang JL
    Tumour Biol; 2016 Jan; 37(1):1025-33. PubMed ID: 26269112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.
    Crose LE; Etheridge KT; Chen C; Belyea B; Talbot LJ; Bentley RC; Linardic CM
    Clin Cancer Res; 2012 Jul; 18(14):3780-90. PubMed ID: 22648271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.
    Sugito N; Taniguchi K; Kuranaga Y; Ohishi M; Soga T; Ito Y; Miyachi M; Kikuchi K; Hosoi H; Akao Y
    Nucleic Acid Ther; 2017 Dec; 27(6):365-377. PubMed ID: 28981396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
    Cinatl J; Cinatl J; Michaelis M; Kabickova H; Kotchetkov R; Vogel JU; Doerr HW; Klingebiel T; Driever PH
    Cancer Res; 2003 Apr; 63(7):1508-14. PubMed ID: 12670897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitumor effects of curcumin in pediatric rhabdomyosarcoma in combination with chemotherapy and phototherapy in vitro.
    Sorg C; Schmid E; Bortel N; Fuchs J; Ellerkamp V
    Int J Oncol; 2021 Feb; 58(2):266-274. PubMed ID: 33491749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.
    Hu K; Lee C; Qiu D; Fotovati A; Davies A; Abu-Ali S; Wai D; Lawlor ER; Triche TJ; Pallen CJ; Dunn SE
    Mol Cancer Ther; 2009 Nov; 8(11):3024-35. PubMed ID: 19887553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.
    Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM
    Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of autocrine secretion of myostatin enhances terminal differentiation in human rhabdomyosarcoma cells.
    Ricaud S; Vernus B; Duclos M; Bernardi H; Ritvos O; Carnac G; Bonnieu A
    Oncogene; 2003 Nov; 22(51):8221-32. PubMed ID: 14614446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.
    Crouch GD; Helman LJ
    Cancer Res; 1991 Sep; 51(18):4882-7. PubMed ID: 1893378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.
    Jacob AG; O'Brien D; Singh RK; Comiskey DF; Littleton RM; Mohammad F; Gladman JT; Widmann MC; Jeyaraj SC; Bolinger C; Anderson JR; Barkauskas DA; Boris-Lawrie K; Chandler DS
    Neoplasia; 2013 Sep; 15(9):1049-63. PubMed ID: 24027430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigallocatechin Gallate Inhibits Cell Growth and Hedgehog Signalling in Human Rhabdomyosarcoma Cell Lines.
    Mayer BFB; Stagno MJ; Fuchs J; Warmann SW; Schmid E
    Anticancer Res; 2023 Mar; 43(3):1025-1030. PubMed ID: 36854509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment.
    Marchesi I; Fais M; Fiorentino FP; Bordoni V; Sanna L; Zoroddu S; Bagella L
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors.
    Hedrick E; Crose L; Linardic CM; Safe S
    Mol Cancer Ther; 2015 Sep; 14(9):2143-53. PubMed ID: 26162688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
    Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
    Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.
    Williams AP; Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    J Surg Res; 2018 Aug; 228():54-62. PubMed ID: 29907230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
    Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
    Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
    Zeng X; An H; Yu F; Wang K; Zheng L; Zhou W; Bao Y; Yang J; Shen N; Huang D
    Neurochem Res; 2021 May; 46(5):1239-1251. PubMed ID: 33646533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
    Ciarapica R; Carcarino E; Adesso L; De Salvo M; Bracaglia G; Leoncini PP; Dall'agnese A; Verginelli F; Milano GM; Boldrini R; Inserra A; Stifani S; Screpanti I; Marquez VE; Valente S; Mai A; Puri PL; Locatelli F; Palacios D; Rota R
    BMC Cancer; 2014 Feb; 14():139. PubMed ID: 24575771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissues.
    Brehm H; Niesen J; Mladenov R; Stein C; Pardo A; Fey G; Helfrich W; Fischer R; Gattenlöhner S; Barth S
    Cancer Lett; 2014 Oct; 352(2):228-35. PubMed ID: 25016058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of HLA class I expression in multidrug-resistant human rhabdomyosarcoma cells.
    Melguizo C; Prados J; Marchal JA; Vélez C; Carrillo E; Boulaiz H; Sánchez-Montesinos I; Madeddu R; Aránega A
    Neoplasma; 2003; 50(2):91-6. PubMed ID: 12740641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.